Home / Companies / Mahana Therapeutics, Inc.

Mahana Therapeutics, Inc.

FDA Regulatory Profile

Mahana Therapeutics, Inc. appears in FDA public data with 0 recalls, 2 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent 510(k) clearance was granted on June 2, 2021.

Summary

Total Recalls
0
510(k) Clearances
2
Inspections
1
Compliance Actions
0

Recent 510(k) Clearances

K-NumberDeviceDate
K211372Mahana Parallel Digital Cognitive Behavioral Therapy (CBT) Mobile Application for Irritable Bowel SyJune 2, 2021
DEN200029ParallelNovember 25, 2020

FDA data resources